Beijing Center for Disease Prevention and Control
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 76,220
- 试验地点
- 11
- 主要终点
- Average rate of chronic hepatitis B accepting antiviral treatment
研究概览
简要总结
Through two-stage stratified cluster sampling, investigators studied the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infection-related liver disease population.
详细描述
Hepatitis B virus (HBV) infection is a major public health problem worldwide. China has the world's largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030. While, the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infections is still unknown. In response to the above situation, Sampling applied a two-stage stratified cluster sampling design in 16 Districts and 331 Townships. Investigators wanted to know the one who is eligible for treated criteria based on community in 25 and over years old in Beijing.
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 25 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •older than 25 years old;
- •Residents with medical insurance coverage lived in Beijing more than 6 months .
排除标准
- •Persons with pacemakers;
- •Pregnant women;
- •Persons with ascites;
- •The one whose wound was not cured at the right upper abdomen
结局指标
主要结局
Average rate of chronic hepatitis B accepting antiviral treatment
时间窗: Baseline
The one who is eligible for HBV treated criteria based on community in 25 and over years old in Beijing.
HBsAg positive rate
时间窗: Baseline
Complete HBsAg tests for more than 60,000 people over the age of 25 in Beijing
次要结局
未报告次要终点
研究者
Wu Jiang
Director of institue for immunization and prevention of Beijing CDC
Centers for Disease Control and Prevention, China